Skip to main content
SpringerLink
Log in

Transcatheter Aortic Valve Implantation

  • Chapter
  • First Online:
Mastering Endovascular Techniques

  • 98 Accesses

Abstract

Transcatheter aortic valve implantation (TAVI), also known as transcatheter aortic valve replacement (TAVR), is a revolutionary minimally invasive procedure designed to treat severe aortic stenosis in patients who are deemed high-risk or inoperable for traditional surgical aortic valve replacement. This innovative technique involves the percutaneous delivery and deployment of a bioprosthetic valve via a catheter-based system, obviating the need for open-heart surgery.

TAVI has gained widespread acceptance and popularity due to its remarkable clinical outcomes and reduced perioperative morbidity and mortality compared to conventional surgical interventions. The procedure is typically performed using either transfemoral, transapical, transaortic, or trans-subclavian approaches, catering to a diverse range of patient anatomies and clinical conditions. Various types of transcatheter heart valves are available, including balloon-expandable and self-expanding valves, each offering distinct advantages in specific patient cohorts.

Long-term follow-up data indicate excellent valve functionality and sustained clinical benefits, making TAVI a transformative treatment option for elderly patients with severe aortic stenosis. Nonetheless, ongoing research and advancements in technology continue to refine and expand the indications for TAVI, offering new hope to patients who were once considered ineligible for valve replacement.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.

    Article  PubMed  Google Scholar 

  2. Yadgir S, Johnson CO, Aboyans V, Adebayo OM, Adedoyin RA, Afarideh M, et al. Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990-2017. Circulation. 2020;141(21):1670–80.

    Article  PubMed  Google Scholar 

  3. Lindman BR, Clavel MA, Mathieu P, Iung B, Lancellotti P, Otto CM, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Genereux P, Pibarot P, Redfors B, Mack MJ, Makkar RR, Jaber WA, et al. Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38(45):3351–8.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91.

    Article  PubMed  Google Scholar 

  6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    Article  CAS  PubMed  Google Scholar 

  7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.

    Article  CAS  PubMed  Google Scholar 

  8. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.

    Article  CAS  PubMed  Google Scholar 

  9. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.

    Article  CAS  PubMed  Google Scholar 

  10. Carroll JD, Mack MJ, Vemulapalli S, Herrmann HC, Gleason TG, Hanzel G, et al. STS- ACC TVT registry of transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;76(21):2492–516.

    Article  CAS  PubMed  Google Scholar 

  11. Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, et al. Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2015;66(25):2827–38.

    Article  PubMed  Google Scholar 

  12. Spitzer E, Van Mieghem NM, Pibarot P, Hahn RT, Kodali S, Maurer MS, et al. Rationale and design of the Transcatheter aortic valve replacement to UNload the left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80–8.

    Article  PubMed  Google Scholar 

  13. Strange G, Stewart S, Celermajer D, Prior D, Scalia GM, Marwick T, et al. Poor long- term survival in patients with moderate aortic stenosis. J Am Coll Cardiol. 2019;74(15):1851–63.

    Article  PubMed  Google Scholar 

  14. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23–42.

    Article  PubMed  Google Scholar 

  15. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44; discussion 44–5.

    Article  PubMed  Google Scholar 

  16. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.

    Article  PubMed  Google Scholar 

  17. Faroux L, Guimaraes L, Wintzer-Wehekind J, Junquera L, Ferreira-Neto AN, Del Val D, et al. Coronary artery disease and transcatheter aortic valve replacement: JACC state-of- the-art review. J Am Coll Cardiol. 2019;74(3):362–72.

    Article  PubMed  Google Scholar 

  18. Witberg G, Regev E, Chen S, Assali A, Barbash IM, Planer D, et al. The prognostic effects of coronary disease severity and completeness of revascularization on mortality in patients undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10(14):1428–35.

    Article  PubMed  Google Scholar 

  19. Thalji NM, Suri RM, Daly RC, Greason KL, Dearani JA, Stulak JM, et al. The prognostic impact of concomitant coronary artery bypass grafting during aortic valve surgery: implications for revascularization in the transcatheter era. J Thorac Cardiovasc Surg. 2015;149(2):451–60.

    Article  PubMed  Google Scholar 

  20. Thiele H, Kurz T, Feistritzer HJ, Stachel G, Hartung P, Lurz P, et al. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Circulation. 2020;142(15):1437–47.

    Article  CAS  PubMed  Google Scholar 

  21. Dangas GD, Lefevre T, Kupatt C, Tchetche D, Schafer U, Dumonteil N, et al. Bivalirudin versus heparin anticoagulation in transcatheter aortic valve replacement: the randomized BRAVO-3 trial. J Am Coll Cardiol. 2015;66(25):2860–8.

    Article  CAS  PubMed  Google Scholar 

  22. Brinkert M, Mangner N, Moriyama N, Keller LS, Hagemeyer D, Crusius L, et al. Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants. JACC Cardiovasc Interv. 2021;14(2):135–44.

    Article  PubMed  Google Scholar 

  23. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075–128.

    Article  PubMed  Google Scholar 

  24. Stortecky S, Heg D, Tueller D, Pilgrim T, Muller O, Noble S, et al. Infective endocarditis after transcatheter aortic valve replacement. J Am Coll Cardiol. 2020;75(24):3020–30.

    Article  PubMed  Google Scholar 

  25. van Wiechen MP, Tchetche D, Ooms JF, Hokken TW, Kroon H, Ziviello F, et al. Suture- or plug-based large-bore arteriotomy closure: a pilot randomized controlled trial. JACC Cardiovasc Interv. 2021;14(2):149–57.

    Article  PubMed  Google Scholar 

  26. Vavuranakis M, Kalogeras KI, Vrachatis DA, Kariori MG, Aznaouridis K, Moldovan C, et al. A modified technique to safely close the arterial puncture site after TAVI. J Invasive Cardiol. 2013;25(1):45–7.

    PubMed  Google Scholar 

  27. Lanz J, Greenbaum A, Pilgrim T, Tarantini G, Windecker S. Current state of alternative access for transcatheter aortic valve implantation. EuroIntervention. 2018;14(AB):AB40–52.

    Article  PubMed  Google Scholar 

  28. Dahle TG, Kaneko T, McCabe JM. Outcomes following subclavian and axillary artery access for transcatheter aortic valve replacement: Society of the Thoracic Surgeons/American College of Cardiology TVT registry report. JACC Cardiovasc Interv. 2019;12(7):662–9.

    Article  PubMed  Google Scholar 

  29. Bapat V, Khawaja MZ, Attia R, Narayana A, Wilson K, Macgillivray K, et al. Transaortic transcatheter aortic valve implantation using Edwards Sapien valve: a novel approach. Catheter Cardiovasc Interv. 2012;79(5):733–40.

    Article  PubMed  Google Scholar 

  30. Chamandi C, Abi-Akar R, Rodes-Cabau J, Blanchard D, Dumont E, Spaulding C, et al. Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2018;11(11):e006388.

    Article  PubMed  Google Scholar 

  31. Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585–95.

    Article  PubMed  Google Scholar 

  32. Pibarot P, Hahn RT, Weissman NJ, Arsenault M, Beaudoin J, Bernier M, et al. Association of paravalvular regurgitation with 1-year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 valve. JAMA Cardiol. 2017;2(11):1208–16.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Ribeiro HB, Nombela-Franco L, Urena M, Mok M, Pasian S, Doyle D, et al. Coronary obstruction following transcatheter aortic valve implantation: a systematic review. JACC Cardiovasc Interv. 2013;6(5):452–61.

    Article  PubMed  Google Scholar 

  34. Abramowitz Y, Chakravarty T, Jilaihawi H, Kashif M, Kazuno Y, Takahashi N, et al. Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients. EuroIntervention. 2015;11(5):572–81.

    Article  PubMed  Google Scholar 

  35. Pasic M, Unbehaun A, Buz S, Drews T, Hetzer R. Annular rupture during transcatheter aortic valve replacement: classification, pathophysiology, diagnostics, treatment approaches, and prevention. JACC Cardiovasc Interv. 2015;8(1 Pt A):1–9.

    Article  PubMed  Google Scholar 

  36. Kim WK, Schafer U, Tchetche D, Nef H, Arnold M, Avanzas P, et al. Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt valve EmboLization and migration). Eur Heart J. 2019;40(38):3156–65.

    Article  PubMed  Google Scholar 

  37. Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.

    Article  PubMed  Google Scholar 

  38. Genereux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER valve) trial. J Am Coll Cardiol. 2012;60(12):1043–52.

    Article  PubMed  Google Scholar 

  39. Scarsini R, De Maria GL, Joseph J, Fan L, Cahill TJ, Kotronias RA, et al. Impact of complications during transfemoral transcatheter aortic valve replacement: how can they be avoided and managed? J Am Heart Assoc. 2019;8(18):e013801.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Maeno Y, Abramowitz Y, Kawamori H, Kazuno Y, Kubo S, Takahashi N, et al. A highly predictive risk model for pacemaker implantation after TAVR. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1139–47.

    Article  PubMed  Google Scholar 

  41. Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019;40(38):3143–53.

    Article  PubMed  Google Scholar 

  42. Vlastra W, Jimenez-Quevedo P, Tchetche D, Chandrasekhar J, de Brito FS Jr, Barbanti M, et al. Predictors, incidence, and outcomes of patients undergoing transfemoral transcatheter aortic valve implantation complicated by stroke. Circ Cardiovasc Interv. 2019;12(3):e007546.

    Article  PubMed  Google Scholar 

  43. Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021;143(5):e35–71.

    PubMed  Google Scholar 

  44. Brouwer J, Nijenhuis VJ, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020;383(15):1447–57.

    Article  CAS  PubMed  Google Scholar 

  45. Nijenhuis VJ, Brouwer J, Delewi R, Hermanides RS, Holvoet W, Dubois CLF, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020;382(18):1696–707.

    Article  CAS  PubMed  Google Scholar 

  46. Vavuranakis M, Kalogeras K, Kolokathis AM, Vrachatis D, Magkoutis N, Siasos G, et al. Antithrombotic therapy in TAVI. J Geriatr Cardiol. 2018;15(1):66–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Kalogeras K, Jabbour RJ, Ruparelia N, Watson S, Kabir T, Naganuma T, et al. Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry. J Thromb Thrombolysis. 2020;50(1):82–9.

    Article  CAS  PubMed  Google Scholar 

  48. Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, et al. Long-term durability of transcatheter aortic valve prostheses. J Am Coll Cardiol. 2019;73(5):537–45.

    Article  PubMed  Google Scholar 

  49. Testa L, Latib A, Brambilla N, De Marco F, Fiorina C, Adamo M, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J. 2020;41(20):1876–86.

    Article  PubMed  Google Scholar 

  50. Sondergaard L, Ihlemann N, Capodanno D, Jorgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73(5):546–53.

    Article  PubMed  Google Scholar 

  51. Pibarot P, Ternacle J, Jaber WA, Salaun E, Dahou A, Asch FM, et al. Structural deterioration of transcatheter versus surgical aortic valve bioprostheses in the PARTNER-2 trial. J Am Coll Cardiol. 2020;76(16):1830–43.

    Article  PubMed  Google Scholar 

  52. Rodriguez-Gabella T, Voisine P, Puri R, Pibarot P, Rodes-Cabau J. Aortic bioprosthetic valve durability: incidence, mechanisms, predictors, and management of surgical and transcatheter valve degeneration. J Am Coll Cardiol. 2017;70(8):1013–28.

    Article  PubMed  Google Scholar 

  53. Capodanno D, Petronio AS, Prendergast B, Eltchaninoff H, Vahanian A, Modine T, et al. Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38(45):3382–90.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Cardiology, Sotiria Hospital, Medical School, Athens, Greece

    Konstantinos Kalogeras

  2. Third Department of Cardiology, National and Kapodistrian University of Athens, Sotiria Hospital, Medical School, Athens, Greece

    Manolis Vavuranakis

Authors
  1. Konstantinos Kalogeras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manolis Vavuranakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. National and Kapodistrian University of Athens, Athens, Greece

    George Geroulakos

  2. Department of Vascular Surgery, Attikon Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Efthymios Avgerinos

  3. Henri Mondor Hôspital, APHP Créteil, Hôpital Privé Paris East, Ramsay Santé, Créteil, France

    Jean Pierre Becquemin

  4. Vascular and Interventional Radiology, Guy's and St Thomas' NHS Foundation Trust, London, UK

    Gregory C. Makris

  5. Vascular Surgery, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

    Alberto Froio

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kalogeras, K., Vavuranakis, M. (2024). Transcatheter Aortic Valve Implantation. In: Geroulakos, G., Avgerinos, E., Becquemin, J.P., Makris, G.C., Froio, A. (eds) Mastering Endovascular Techniques. Springer, Cham. https://doi.org/10.1007/978-3-031-42735-0_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-42735-0_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-42734-3

  • Online ISBN: 978-3-031-42735-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation